J Korean Neurol Assoc.
2003 Apr;21(2):217-219.
A Case of Cerebral Infarction Following Intravenous Immunoglobulin Therapy in a Patient with Guillain-Barre Syndrome
- Affiliations
-
- 1Department of Neurology, College of Medicine, Cheju National University, 1 Ara 1-dong, Jeju-si, Jeju, 690-756, Korea. neurokang@cheju.ac.kr
Abstract
- Intravenous immunoglobulin (IVIg) therapy is being increasingly used in a wide range of neurological conditions. Although IVIg is generally regarded as being safe, there are reports of acute renal failure, aseptic meningitis, and unexplained stroke or thromboembolic events in elderly patients. We report a patient with Guillain-Barre syndrome who developed a cerebral infarction following intravenous immunoglobulin therapy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Guillain-Barre Syndrome Following Acute Cerebral Infarction
- A Case of Rapid Improvement of Symptoms in Severe Guillain-Barre Syndrome after Additional Use of Intravenous Immunoglobulin
- A Case of Pompholyx Following Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome
- Pulmonary Thromboembolism after Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome
- Pseudohyponatremia After Intravenous Immunoglobulin Therapy in a Patient With Guillain-Barre Syndrome
